The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
Open accessAbstract
Background Atopic dermatitis (AD) is a common skin disease that is characterized by recurrent episodes of itching. Filaggrin loss-of-function mutations (FLG null) have been associated with an increased risk of developing AD. Objective To evaluate the effect of individual FLG null mutations on the persistence of AD over time. Methods We evaluated a multiyear prospective cohort study of children with AD with respect to FLG null mutations (R501X, 2282del4, R2447X, and S3247X). We evaluated the association of these mutations with the persistence of AD symptoms over time, with respect to reports of no symptoms of AD and whether topical medication was needed for symptom resolution. Results 857 subjects were followed for 3,684 person-years. One or more FLG null mutations were noted in 16.3% of subjects and specifically in 27.5% of whites and 5.8% of African-Americans. Individuals with a FLG null mutation were less likely [OR: 0.54 (95% CI: 0.41, 0.71)] to report that their skin was symptom-free at any time as compared to those without a FLG null mutation. The effect of these mutations was similar in whites [0.42 (0.31, 0.57) and African-Americans 0.53 (0.25, 1.12) (p=0.62)]. Children with the R501X mutation [0.44 (0.22, 0.88)] were the least responsive to therapy. Conclusions In a US cohort with AD, FLG null mutations were common. Children with FLG null mutations were more likely to have persistent AD. Although, these mutations were more common in those of European ancestry, their effect on persistence was similar in those of African ancestry. Response to therapy was not uniform among children with FLG null mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Self-citationWILLIAMS, H. C., JBURNEY, P. G., HAY, R. J., ARCHER, C. B., SHIPLEY, M. J., AHUNTER, J. J., BINGHAM, E. A., FINLAY, A. Y., PEMBROKE, A. C., CGRAHAM-BROWN, R. A., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08530.x · Cited by 1,271
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Self-citationOne remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527
Gustafsson, D., Sjöberg, O., & Foucard, T. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00391.x · Cited by 457
Genetic evidence for the convergent evolution of light skin in Europeans and East Asians
Norton, H. L., Kittles, R. A., Parra, E., McKeigue, P., Mao, X., Cheng, K., Canfield, V. A., Bradley, D. G., McEvoy, B., & Shriver, M. D. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl203 · Cited by 410
Fonacier, L. S., Dreskin, S. C., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.039 · Cited by 139
Cited by
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Brunner, P. M., Guttman-Yassky, E., & Leung, D. Y. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.011 · Cited by 642
Atopic dermatitis endotypes and implications for targeted therapeutics
Czarnowicki, T., He, H., Krueger, J. G., & Guttman-Yassky, E. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.032 · Cited by 631
Staphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
Zheng, T. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000202 · Cited by 497
Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches
Leung, D. Y. M., & Guttman-Yassky, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.008 · Cited by 474
The multifunctional role of filaggrin in allergic skin disease
McAleer, M. A., & Irvine, A. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.668 · Cited by 419
Kaufman, B. P., Guttman‐Yassky, E., & Alexis, A. F. (2018) · Experimental Dermatology · doi:10.1111/exd.13514 · Cited by 359
New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
Leung, D. Y. M. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0564 · Cited by 331
Guttman-Yassky, E., Renert-Yuval, Y., & Brunner, P. M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02519-4 · Cited by 321
Yew, Y. W., Thyssen, J. P., & Silverberg, J. I. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.09.035 · Cited by 309
Racial differences in atopic dermatitis
Brunner, P. M., & Guttman-Yassky, E. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.11.015 · Cited by 282
Persistence of Mild to Moderate Atopic Dermatitis
Margolis, J. S., Abuabara, K., Bilker, W., Hoffstad, O., & Margolis, D. J. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.10271 · Cited by 276
Self-citationMargolis, D. J., Gupta, J., Apter, A. J., Ganguly, T., Hoffstad, O., Papadopoulos, M., Rebbeck, T. R., & Mitra, N. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.015 · Cited by 175
Self-citationA functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis
Esparza-Gordillo, J., Schaarschmidt, H., Liang, L., Cookson, W., Bauerfeind, A., Lee-Kirsch, M.-A., Nemat, K., Henderson, J., Paternoster, L., Harper, J. I., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.057 · Cited by 107
Genetics and epigenetics of atopic dermatitis: an updated systematic review
Martin, M. J., Estravís, M., García-Sánchez, A., Dávila, I., Isidoro-García, M., & Sanz, C. (2020) · Genes · doi:10.3390/genes11040442 · Cited by 99
Sargen, M. R., Hoffstad, O., & Margolis, D. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.274 · Cited by 99
Self-citationLoss of Mpzl3 Function Causes Various Skin Abnormalities and Greatly Reduced Adipose Depots
Leiva, A. G., Chen, A. L., Devarajan, P., Chen, Z., Damanpour, S., Hall, J. A., Bianco, A. C., Li, J., Badiavas, E. V., Zaias, J., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.94 · Cited by 31
Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age
Wan, J., Mitra, N., Hoffstad, O. J., & Margolis, D. J. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2017.04.003 · Cited by 19
Self-citationKim, H.-S., Hwang, H.-J., Seo, W.-D., & Do, S.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417274 · Cited by 18
Metadata
- Authors
- Margolis, D. J., Apter, A. J., Gupta, J., Hoffstad, O., Papadopoulos, M., Campbell, L. E., Sandilands, A., McLean, W. H. I., Rebbeck, T. R., & Mitra, N.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 130
- Issue
- 4
- Pages
- 912-917
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W1984314853
- Cited by
- 217
- References
- 7
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.